Growth Metrics

Vanda Pharmaceuticals (VNDA) Assets Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -12.38%
Dec 31, 2025 -8.31%
Sep 30, 2025 -1.12%
Jun 30, 2025 0.85%
Mar 31, 2025 1.54%
Dec 31, 2024 3.39%
Sep 30, 2024 3.62%
Jun 30, 2024 4.69%
Mar 31, 2024 6.31%
Dec 31, 2023 6.72%
Sep 30, 2023 7.54%
Jun 30, 2023 8.20%
Mar 31, 2023 9.68%
Dec 31, 2022 9.45%
Sep 30, 2022 9.43%
Jun 30, 2022 17.81%
Mar 31, 2022 19.78%
Dec 31, 2021 21.37%
Sep 30, 2021 22.95%
Jun 30, 2021 23.29%
Mar 31, 2021 19.62%
Dec 31, 2020 37.45%
Sep 30, 2020 35.86%
Jun 30, 2020 33.98%
Mar 31, 2020 33.63%
Dec 31, 2019 31.99%
Sep 30, 2019 31.54%
Jun 30, 2019 22.62%
Mar 31, 2019 19.32%
Dec 31, 2018 15.95%
Sep 30, 2018 12.25%
Jun 30, 2018 10.64%
Mar 31, 2018 14.10%
Dec 31, 2017 6.16%
Sep 30, 2017 37.47%
Jun 30, 2017 34.71%
Mar 31, 2017 19.16%
Dec 31, 2016 13.64%
Sep 30, 2016 10.36%
Jun 30, 2016 19.99%
Mar 31, 2016 18.22%
Dec 31, 2015 16.30%
Sep 30, 2015 13.76%
Jun 30, 2015 11.62%
Mar 31, 2015 7.37%
Dec 31, 2014 -2.03%
Sep 30, 2014 -26.04%
Jun 30, 2014 -24.90%
Dec 31, 2013 -12.38%